Article: L. Rhamnosus GR-1 and L. Reuteri RC-14 effective in treating bacterial vaginosis.(RESEARCH HIGHLIGHTS)(Brief article)

A new study published in Microbes and Infections demonstrates that the probiotic strains Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 are effective in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina. Jarrow Formulas' (Los Angeles, CA) Fem-Dophilus is a branded vaginal probiotics product consisting of the exact strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, used in the study.

The study enrolled 125 pre-menopausal women diagnosed with BV. The subjects were treated with oral metronidazole (500 mg) twice daily ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!